Hutchison China’s Medipharma Agrees to Collaboration Deal With Eli Lilly

Hutchison China Meditech, the China-based pharmaceutical company, said its unit Hutchison MediPharma has agreed a research collaboration with U.S. pharmaceutical company Eli Lilly to codevelop oncology and anti-inflammatory medicines.
ABC Money.co.uk